ATE522808T1 - Verfahren zur bestimmung der aktivierung von leukozyten - Google Patents

Verfahren zur bestimmung der aktivierung von leukozyten

Info

Publication number
ATE522808T1
ATE522808T1 AT01980741T AT01980741T ATE522808T1 AT E522808 T1 ATE522808 T1 AT E522808T1 AT 01980741 T AT01980741 T AT 01980741T AT 01980741 T AT01980741 T AT 01980741T AT E522808 T1 ATE522808 T1 AT E522808T1
Authority
AT
Austria
Prior art keywords
platelet
leukocyte activation
component
determining
determining leukocyte
Prior art date
Application number
AT01980741T
Other languages
English (en)
Inventor
Marion Macey
Original Assignee
Barts And The London Nat Health Service Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barts And The London Nat Health Service Trust filed Critical Barts And The London Nat Health Service Trust
Application granted granted Critical
Publication of ATE522808T1 publication Critical patent/ATE522808T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving
AT01980741T 2000-11-08 2001-11-08 Verfahren zur bestimmung der aktivierung von leukozyten ATE522808T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0027309.4A GB0027309D0 (en) 2000-11-08 2000-11-08 Method of measuring measuring platlet activation
PCT/GB2001/004946 WO2002039124A1 (en) 2000-11-08 2001-11-08 Method of measuring platelet activation

Publications (1)

Publication Number Publication Date
ATE522808T1 true ATE522808T1 (de) 2011-09-15

Family

ID=9902807

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01980741T ATE522808T1 (de) 2000-11-08 2001-11-08 Verfahren zur bestimmung der aktivierung von leukozyten

Country Status (9)

Country Link
US (1) US7011938B2 (de)
EP (1) EP1332373B1 (de)
JP (1) JP2004513369A (de)
AT (1) ATE522808T1 (de)
AU (2) AU2002212529B2 (de)
CA (1) CA2428224C (de)
ES (1) ES2372810T3 (de)
GB (1) GB0027309D0 (de)
WO (1) WO2002039124A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2392724A (en) * 2002-09-06 2004-03-10 Ian Stoakes Methods of and apparatus for blood analysis
EP1814563A4 (de) * 2004-07-26 2008-04-16 Bayer Healthcare Llc Plättchenaktivierungsmarker als prädikatoren von erkrankungen und der reaktion auf behandlungen sowie zur überwachung des therapeutischen fortschritts
US7811549B2 (en) 2006-07-05 2010-10-12 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
US8021854B2 (en) * 2007-10-05 2011-09-20 Attila Mady Method of treating vascular disease
US8835104B2 (en) 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
US20090185973A1 (en) * 2008-01-22 2009-07-23 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
AU2012240016B2 (en) 2011-04-07 2016-11-10 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
DK3054936T5 (da) 2013-10-10 2024-03-18 Eastern Virginia Medical School 4-((2-hydroxy-3-methoxybenzyl)amino) benzensulfonamid derivater som 12-lipoxygenase inhibitorer
EP3698628A1 (de) 2014-08-07 2020-08-26 The General Hospital Corporation Stabilisierung von vollblutproben
GB2553898B (en) 2016-07-12 2021-04-07 Emulate Inc Additive channels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08220094A (ja) * 1995-02-08 1996-08-30 Dai Ichi Pure Chem Co Ltd 血漿中ｇｍｐ−１４０の測定法
FR2731277A1 (fr) * 1995-03-02 1996-09-06 Benveniste Jacques Procedes et appareil pour faciliter la purification, le comptage et la mesure de l'activation des leucocytes sanguins
US5817519A (en) * 1995-12-28 1998-10-06 Bayer Corporation Automated method and device for identifying and quantifying platelets and for determining platelet activation state using whole blood samples
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease

Also Published As

Publication number Publication date
AU1252902A (en) 2002-05-21
CA2428224C (en) 2010-04-27
JP2004513369A (ja) 2004-04-30
WO2002039124A1 (en) 2002-05-16
US20040038997A1 (en) 2004-02-26
EP1332373A1 (de) 2003-08-06
EP1332373B1 (de) 2011-08-31
CA2428224A1 (en) 2002-05-16
US7011938B2 (en) 2006-03-14
GB0027309D0 (en) 2000-12-27
ES2372810T3 (es) 2012-01-26
AU2002212529B2 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
ATE522808T1 (de) Verfahren zur bestimmung der aktivierung von leukozyten
DE69011198T2 (de) Verfahren zur Differenzierung von Leukozyten mit Hilfe eines Durchflusszellmessgerätes.
DE3853671T2 (de) Reagens und Verfahren zur Messung von Leukozyten und Hämoglobin im Blut.
DE3685930T2 (de) Verfahren zur bestimmung von mimitopen.
DE69022786T2 (de) Verfahren zur Bestimmung der Konzentration von Glucose.
EP1212613A4 (de) Hämatologische kontrolle und system für hämatologische viel-parameter-messungen
ES530969A0 (es) Un reactivo estromatolizante para uso en la determinacion de las poblaciones de leucocitos en sangre
DE69434942D1 (de) Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
DE3587036D1 (de) Verfahren und reagenziensystem zur differentiellen bestimmung vierer populationen von leukozyten.
ATE540319T1 (de) Verfahren für die bestimmung von fk506
DE60033380D1 (de) Verfahren zur quantifizierung der zahl von leukozyten in einer blutprobe
DE3887694D1 (de) Vorrichtung zur bestimmung der koagulationszeit einer blutprobe.
DE69731504D1 (de) Reagenz und Verfahren zur Freisetzung und Bestimmung von Blei in biologischen Matrices
ATE256286T1 (de) Standard zur blutkontrolle
DE69411898D1 (de) Neue antikoagulant-cofaktor aktivität
DE3789310D1 (de) Verfahren zur feststellung der entwicklungsgeschichte eines körperzustandes aus einer einzigen blutprobe.
DE69124030D1 (de) Testverfahren, die ein lösliches fibrinähnliches Monomer nutzen
ATE64470T1 (de) Verfahren und zusammensetzungen zur bestimmung von heparin.
DE69420311T2 (de) Verfahren und Zusammensetzung zum Lysieren von Erythrozyten, Blutzusammensetzungen und Verfahren zur Leukozytanalyse
ATE465411T1 (de) Verfahren zur bestimmung von anfälligkeit einer person zur infektion
ATE347613T1 (de) Verfahren zur bestimmung von alkalischer phosphatase unter beseitigung von hämoglobin- störungen
DE502004011984D1 (de) Verfahren zur Bestimmung des Vorhandenseins von Thrombozyteninhibitoren in einer Blutprobe
RU96119224A (ru) Способ измерения адгезии тромбоцитов
DE58907208D1 (de) Verfahren zur Bestimmung von Antikörpern.
ATE269971T1 (de) Verfahren zur prüfung von immunokompetenz

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties